Danaher Co. (NYSE:DHR) Shares Sold by Deutsche Bank AG

Deutsche Bank AG lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 8.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,407,746 shares of the conglomerate's stock after selling 233,295 shares during the period. Deutsche Bank AG owned 0.33% of Danaher worth $552,698,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the fourth quarter worth approximately $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher during the 4th quarter worth $31,000. Hurley Capital LLC purchased a new position in Danaher during the 4th quarter worth $34,000. Finally, Pineridge Advisors LLC increased its stake in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 57 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Price Performance

NYSE DHR traded down $5.40 during trading hours on Friday, reaching $189.42. The company's stock had a trading volume of 4,535,806 shares, compared to its average volume of 3,411,207. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company's 50-day moving average is $198.39 and its two-hundred day moving average is $219.21. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The stock has a market cap of $135.56 billion, a PE ratio of 35.88, a PEG ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The business had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Analysts forecast that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's payout ratio is currently 24.85%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on DHR. Wells Fargo & Company lowered their price target on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Barclays lifted their target price on Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research note on Tuesday, April 22nd. Royal Bank of Canada reaffirmed an "outperform" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Citigroup reissued a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Finally, The Goldman Sachs Group reduced their target price on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $264.40.

Insiders Place Their Bets

In related news, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares in the company, valued at approximately $3,005,442. The trade was a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.